Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 77,667 shares between June 15 and June 19 at an average price of €24.66, for a total expenditure of approximately €1.9 million. Following these transactions, the company holds 116,204 of its own ordinary shares as of market close on June 19, 2026.
Key figures
- Average price eur
- 24.6586
- Shares repurchased
- 77667
- Total treasury shares
- 116204
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.